Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.
Press releases published on September 11, 2025
EIN Presswire Unveils First Case Study on Using Press Releases to Increase AI Search Visibility and Media Coverage
How My Home Pathway leveraged EIN Presswire to expand reach, enhance AI search visibility, and build media momentum. WASHINGTON , DC, UNITED STATES, September 11, 2025 /EINPresswire.com/ -- It’s no secret that people are increasingly using artificial …
Annual Virginia IPT Sunset Polo™ Unites Fashion Icons and Celebrity Athletes to Champion Cancer Charity
MIDDLEBURG, VA, UNITED STATES, September 11, 2025 /EINPresswire.com/ -- This past weekend, the city of Middleburg, Virginia became more than the home of annual We Will Survive Cancer IPT Sunset Polo™ festivities- it became a center for life-changing …
Domestic Metals Provides Project Update for Ongoing Field Level Exploration at the Smart Creek Project
VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (the “Company” or “Domestic”) - (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) provides an exploration update for field level activities at the Smart Creek Project located in …
Political Uncertainty Tests Indonesia's Growth Story as Markets Reprice Risk
Indonesia’s 5.12% GDP rise meets unrest-driven jitters, EBC Financial Group highlights investor caution. INDONESIA, September 11, 2025 /EINPresswire.com/ -- Indonesia’s economy grew a robust 5.12% year-on-year in Q2, underscoring its resilience as a …
One Carbon World joins Carbon Markets Africa Summit as official climate impact partner
JOHANNESBURG , GAUTENG , SOUTH AFRICA, September 11, 2025 /EINPresswire.com/ -- One Carbon World (OCW) will be the official climate impact partner of the upcoming Carbon Markets Africa Summit (CMAS) taking place in Johannesburg from 22 to 23 October. …
Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of …
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
BOSTON and SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
XS.com Lidera como Patrocinador Global na Traders Fair South Africa 2025
BRAZIL, September 11, 2025 /Business News/ -- A XS.com, provedora global de trading multiativos e fintech, participará como Patrocinador Global da Traders Fair South Africa 2025, agendada para 20 de setembro no Protea Hotel Johannesburg Wanderers. O …
Faraday Pharmaceuticals to Participate in Upcoming Investor Events
SEATTLE, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through the …
Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
NPI-001 shows more than 50% reduction in photoreceptor loss caused by RP associated with USH over two years NPI-001 was well tolerated, with no persistent drug-related adverse events Results were leveraged to design confirmatory trial planned for 2026 FORT …
Rio Silver arranges $1.3M private placement
VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Vancouver, British Columbia – September 11, 2025 – Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces private placement of units. Rio Silver Inc. has arranged …
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available treatments for IPF are limited to only two approved drugs …
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th
MOUNTAIN VIEW, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug- …
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
MEXC x Story Network (IP) $1M Campaign Records 1.59B USDT Trading Volume
VICTORIA, Seychelles, Sept. 11, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, has successfully concluded its $1 million prize pool campaign in partnership with Story Network (IP). The campaign attracted over 220,000 participants …
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Sky Pharm SA, signed a …
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
BRIDGEWATER, N.J, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of Amneal’s sodium oxybate oral solution 500 mg/mL Abbreviated New Drug …
CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical
LAS VEGAS, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the receipt of an …
Enlivex CEO Issues Letter to Shareholders Outlining Strategic Roadmap Following Positive Phase IIa Allocetra™ Results
Allocetra™ demonstrated statistically significant and clinically meaningful improvements in pain and function in Phase IIa trial in primary osteoarthritis patients Six-month data expected November 2025; Phase IIb trial initiation planned for Q2 …